Nachrichten zur Hims & Hers Health Aktie

LOS ANGELES, Aug. 12, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation…

The virtual care provider has updated its Hers app to include personalized AI support and provider access, as well as…

Hims & Hers topped Q2 revenue estimates and raised guidance, but missed EPS forecasts, posted a wider net loss, and…

Hims & Hers Health delivered strong Q2 2026 revenue growth but suffered margin compression and negative free cash flow. See…

Hims & Hers Health stock has pulled back recently yet is still up a little over 3x in five years,…

Hims & Hers Health, Inc. has undergone a fundamental structural evolution, transitioning from a direct-to-consumer marketplace for stigmatised wellness products…

Hims & Hers reported 38% second-quarter revenue growth and raised its 2026 outlook as international expansion and subscriber growth accelerated.…

A new class action lawsuit alleges Hims and Hers sent patient information to third parties without consent.…

The story with Hims & Hers Health today is the gap between the selloff and the scoreboard. The stock slipped…

Hims & Hers Health is planning to sell compounded peptides, the company said in a Monday earnings call. The company’s…

Digital health and wellness company Hims & Hers is ready to tap into a multi-billion peptide market if U.S. regulators…

Lowey Dannenberg announces that it filed a class action complaint against Hims & Hers Health, Inc. on behalf of consumers…

Hims & Hers Health (HIMS) is back in focus after its second quarter 2026 earnings, which showed US$753.2 million in…

Bank of America boosted their price objective on Hims & Hers Health from $30.00 to $32.00 and gave the company…

Hims & Hers Health, Inc. reported second-quarter 2026 sales of US$753.21 million, up from US$544.83 million a year earlier, but…

Hims hebt die Umsatzprognose kräftig an – und die Aktie fällt trotzdem. Schuld ist ein Verlust von 37 statt erwarteter…

Hims & Hers Health (NYSE:HIMS) Shares Gap Down - Heres Why…

Shares of Hims Hers Health ($HIMS), a U.S. telehealth firm, fell over 7% in premarket trading on Tuesday after…